Kotobuki pharmaceutical Co., Ltd.

Company Outline

Company Name Kotobuki Pharmaceutical Co., Ltd.
Headquarters
198, Higashigawara, Kamigomyo, Sakaki-machi, Hanishina-gun, Nagano, 389-0697, Japan
MAP
TEL:+81-268-82-2211
FAX:+81-268-82-4008
Tokyo Office
PMO Nihonbashi-Honcho 3F, 4-12-20, Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-0023, Japan
MAP
TEL:+81-3-6363-1260
FAX:+81-3-6363-1261
Osaka Office
Kotoku Building 2F, 4-1-23, Ekimae, Ibaraki-shi, Osaka, 567-0888, Japan
MAP
TEL&FAX:+81-726-21-0877
Founding
February 11, 1949
Capital 100.00 million yen
Representative Director Hiroshi Tomiyama (President and Chief Executive Officer)
Employees 130
Business Description Manufacturing, marketing and import/export of pharmaceuticals.
Corporate Governance

Kotobuki Pharmaceutical Co., Ltd. is committed to maintaining appropriate governance and striving to enhance management transparency.

  • Annual General Meeting of Shareholders: Held every June
  • Board of Directors Meetings: Held as needed
  • Management Meetings: Held as necessary
  • Compliance Framework: Compliant with the Pharmaceutical and Medical Devices Act and GMP
Licenses and Certifications
  • Pharmaceutical Manufacturing License
  • Pharmaceutical Manufacturing and Marketing License
  • GMP Compliance (Nagano Prefecture / PMDA)
  • License for the Use of Radioisotopes (RI Research Facility)
Track Record of Compliance with Regulatory Requirements

Domestic Inspection

  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • Nagano Prefecture (GMP Inspection)

Inspections by foreign authorities, obtaining approvals, and export track record

  • China National Medical Products Administration (NMPA): Approval and Export Track Record
  • Central Drugs Standard Control Organization (CDSCO), India: Approval and Export Track Record
  • Ministry of Food and Drug Safety (MFDS), South Korea: Inspection, Approval, and Export Track Record
  • Taiwan Food and Drug Administration (TFDA): Approval and Export Track Record
  • U.S. Food and Drug Administration (FDA): Export Track Record
  • European Medicines Agency (EMA) and Related Authorities: Export Track Record

List of key executives
President and CEO: Hiroshi Tomiyama, Ph.D.
Director in charge of General Affairs Department: Kazuhiro Satou
Director in charge of Sales Department: Osami Yamaura
Director in charge of Manufacturing Department: Atsushi Noda
Director in charge of Research Promotion Department: Tatsunori Iwai
Outside Director: Wataru Uchida, Ph.D. (Specially Appointed Professor, Tohoku University, Japan)

Manager level
API & Pharmaceutical Factory Manager: Yoshinori Kobayashi
Manager in charge of Development Pharmacology: Taiki Shimada
Manager in charge of Formulation Development: Seiichiro Ikeda
Manager in charge of Pharmaceutical Affairs: Takeshi Shimada, Ph.D.


Auditor
Yuji Yokozeki

Panoramic view of the Headquarters

Tokyo Office

Osaka Office